Viewing nowLestaron 20 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

MFDS item code 201405844 · Approved 2014.12.10 · Insurance code 640902920
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This drug is primarily used in patients with hypercholesterolemia and hyperlipidemia. It is used as an adjunct therapy to lower blood cholesterol levels when primary hypercholesterolemia or mixed hyperlipidemia cannot be controlled by diet and exercise. It is also beneficial for patients with heterozygous familial hypercholesterolemia or homozygous familial hypercholesterolemia alongside dietary measures. It is used to reduce cholesterol and associated protein levels in children aged 10 to 17 with certain conditions. Additionally, it is effective in reducing the risk of stroke, myocardial infarction, and vascular revascularization in middle-aged men and women at high risk for cardiovascular disease. Thus, this drug is used to reduce hyperlipidemia and the risk of cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, regardless of meals. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; it may be increased to a maximum of 20 milligrams daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.
This drug should not be administered to certain patients. For example, it should not be used in patients who are allergic to any component of this drug, patients with severely impaired liver function, patients with muscle disorders, and those with significantly reduced kidney function. Special caution is necessary for pregnant or breastfeeding women and for fertile women who are not using proper contraception. High doses are prohibited in patients at increased risk of muscle disorders, such as those with moderate or severe renal impairment, hypothyroidism, a history of muscle disorders, or alcohol dependence. This drug contains lactose, so it should not be administered to patients with lactose intolerance or related genetic disorders. Regular monitoring of liver health is required when taking this drug, and patients with a history of significant alcohol intake or liver disease should be especially cautious. Patients with hypothyroidism or nephrotic syndrome should treat the underlying disorders before taking this drug. This drug may affect the muscles and can cause serious muscle damage, such as myalgia, myopathy, and, rarely, rhabdomyolysis. If symptoms like myalgia, weakness, or cramps appear, immediately inform a doctor, and blood tests may be necessary to check for muscle damage. Patients at higher risk of muscle damage (e.g., those with renal impairment, the elderly, hypothyroidism, and a history of muscle disorders) should be monitored closely before and after treatment. Some patients may experience transient proteinuria, but this usually does not lead to serious kidney damage. However, regular kidney function tests are recommended with high-dose administration. Asian patients may have increased systemic exposure to this drug, necessitating dose adjustments. While taking this drug, there may be rare side effects such as headache, dizziness, constipation, nausea, abdominal pain, rash, itching, myalgia, generalized weakness, diarrhea, fatigue, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, fainting, generalized pain, muscle cramps, gout, erectile dysfunction, hematuria, thrombocytopenia, amnesia, peripheral neuropathy, cough, sexual dysfunction, gynecomastia, depression, sleep disorders (including insomnia and nightmares), and cognitive impairment. Serious side effects including liver dysfunction, severe skin reactions, severe myasthenia, interstitial lung disease have been reported, and immediate discontinuation of treatment and medical evaluation are required if these symptoms occur. This drug may interact with other medications, so caution is needed when taking it with cyclosporine, fibrates, certain antibiotics, antifungals, antivirals, etc. This drug should not be used during pregnancy, and women who may become pregnant should use appropriate contraception. It is also deemed safe for breastfeeding women to avoid taking this drug. In case of overdose, there is no specific antidote, so treatment should focus on symptoms, and liver and muscle function tests are necessary. Caution is required when driving or operating machinery as dizziness can occur. Before taking this drug, you must consult your doctor or pharmacist to inform them about your health status and any medications you are currently taking, and it should be used safely through regular check-ups and symptom monitoring.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, shortness of breath, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distention, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly sealed container to protect it from air and moisture and should be kept at room temperature between 1 to 30 degrees Celsius. Storing this way will help maintain the drug's effectiveness and prevent deterioration.
Pink round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.